Cost–Utility Analysis of Wireless Versus Catheter‐Based Oesophageal pH Monitoring in the Pre‐Operative Assessment of Anti‐Reflux Surgery: A Decision‐Analytic Model
Open Access
- 28 September 2026
- journal article
- upper gut
- Published by Wiley in Anz Journal of Surgery
Abstract
Background: Distal oesophageal pH testing is an important component of the pre‐operative workup for anti‐reflux surgery, providing diagnostic confirmation and prognostic information. Catheter‐based reflux testing is currently the standard modality in Australia. Although associated with improved patient tolerability, wireless testing remains limited by access and funding restrictions. Methods: A cost–utility analysis was conducted to compare the cost‐effectiveness of wireless versus catheter‐based reflux monitoring before anti‐reflux surgery. Health service costs (administrative, labour, and equipment) and EuroQol 5‐Dimension‐derived utility weights were used to calculate incremental costs per quality‐adjusted life‐year (QALY) over a one‐year time horizon. Results: Wireless pH monitoring was associated with marginally lower costs and higher QALYs compared with catheter‐based monitoring (AUD $11001.51 vs. AUD $11210.47; 0.87 vs. 0.82 QALYs). The base‐case incremental cost‐effectiveness ratio was −AUD $5026.64 per QALY, indicating that wireless monitoring was the dominant strategy. At a willingness‐to‐pay threshold of AUD $50 000 per QALY, the incremental net monetary benefit was AUD $2287.47, indicating potential cost‐effectiveness. One‐way sensitivity analyses suggested that base‐case findings were robust across key parameter variations. Conclusion: Within this model evaluating the pH testing component of the pre‐operative work‐up, wireless monitoring may represent a cost‐effective alternative to catheter‐based monitoring without substantially increasing healthcare costs.Keywords
This publication has 23 references indexed in Scilit:
- AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert ReviewClinical Gastroenterology and Hepatology, 2022
- Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsThe European Journal of Health Economics, 2022
- Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux DiseaseJournal of Clinical Gastroenterology, 2017
- Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleadingDiseases of the Esophagus, 2017
- Impact of laparoscopic Nissen’s fundoplication on response of disease specific symptoms and quality of lifeUpdates in Surgery, 2012
- Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoringScandinavian Journal of Gastroenterology, 2009
- Feasibility and tolerability of transnasal/per‐oral placement of the wireless pH capsule vs. traditional 24‐h oesophageal pH monitoring – a randomized trialAlimentary Pharmacology & Therapeutics, 2005
- Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test resultsThe American Journal of Surgery, 2004
- Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplicationJournal of Gastrointestinal Surgery, 1999
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990